WATCH $PROFBullish
Fundamental
- High inflationary Macro environment / no fear sentiment
- Funds Accumulation
- Decent PE
- Decent PEG
- Decent P/FCF
- Strong Sector / Industry / Leader
- Prostate cancer is the #4 cancer in the world
Technical
- Momentum Theory Indicator - waiting for momentum to break out
- Momentum divergence on the MTI 02
- Price action formation ( dowtrend channel )
- Broke Trend line / retest needs to hold
- Below 200MA
- Below POC
- Pending ST
- No bullish Candlestick
PROF / SPY
Entry idea
- For members
Stop loss depending on entry and risk appetite. But always set meaningful stops.
Get comfortable being uncomfortable
Cheers and happy trading!
PRN trade ideas
Trial Data offers Pennant/Flag breakout opportunity in PRN/PRFMFProfound Medical, a Canadian medical device company, traded on the Toronto Stock Exchange under the symbol PRN or PRFMF on the US exchange, has provided a nice Bullish Pennant/Flag formation. The pennant formation has formed over the last two months and broke out this morning on heavy volume, in reaction to its Phase 3 prostate cancer trials. Bullish pennants usually require heavy volume on the breakout, which we are seeing today. Additionally, the price target for bullish pennants are usually established by the flag pole height, which in this case is roughly .42, which would put the expected price target just under $1.25.
Phase 3 trial data offers flag breakout opprotunity in PRN/PRFMFProfound Medical which is a Canadian company traded on the Toronto Stock Exchange under the symbol PRN or PRFMF on the US exchange, has provided a nice Bullish Pennant/Flag formation. The pennant formation has formed over the last two months and broke out this morning on heavy volume in reaction to its Phase 3 prostate cancer trials. Bullish pennants usually require heavy volume on the breakout, which we are seeing today. In addition, the price target for bullish pennants are usually established by the flag poles height, which in this case would put the expected price target just under $1.25.